Vascular BioSciences to Present to Investors at "Spotlight on Life Sciences," Hosted by TechVentures Network and the Venture Consulting Group

Vascular BioSciences showcased to life sciences investor panel.

San Diego, Calif. - Vascular BioSciences (www.vascularbiosciences.com) announced today it will present to investors at the "Spotlight on Life Sciences," part of the 2003 Venture Showcase Series, hosted by TechVentures Network and the Venture Consulting Group on Wednesday, May 28 in Oakland, California. For event information, visit www.techventuresnetwork.org/Ventureshowcase.htm.

"Spotlight on Life Sciences" features a select group of promising, early-stage companies poised to change the biotechnology and healthcare markets.

As part of this select group, Vascular BioSciences will describe its innovative, new technology, the endoarterial biopsy catheter. The catheter safely obtains biopsy samples from the inner layers of arteries in a minimally invasive procedure. These biopsy samples can then be used to better enable the study, diagnosis, monitoring, and treatment of vascular-based diseases that affect more than 2 million people in the United States alone. Diseases and medical conditions that can benefit from the catheter include pulmonary hypertension, lung cancer, pulmonary manifestations of collagen vascular diseases such as lupus and scleroderma, vasculitis, and lung transplant rejection. The endoarterial biopsy catheter also has applications in the area of drug development and patient selection for clinical trials.

"Weve completed our pre-clinical development and are ready for clinical trials," said David Mann, CEO of Vascular BioSciences. "We are excited at the opportunity to present our company to the investment community at this event."

About Vascular BioSciences:

Vascular BioSciences, a privately held medical device company based in San Diego, California, has developed the endoarterial biopsy catheter to percutaneously obtain biopsy samples from the inner layers of blood vessels.

Vascular BioSciences is dedicated to developing innovative technologies to detect and treat vascular-based diseases in order to enhance and prolong human life.